Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elevance Health, Inc.ELV · Entity 2934 | EVP & Pres Carelon & CarelonRx | March 02, 2026 | March 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elevance Health, Inc.
Report date March 02, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,222 |
Ending reported balance
After 2026-03-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-03-02 · Tax withholding · Disposed 1,201 · Balance 24,803 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Row 2 · 2026-03-02 · Grant · Acquired 2,865 · Balance 27,668 F2: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026. Row 3 · 2026-03-03 · Tax withholding · Disposed 446 · Balance 27,222 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
Filing footnotes · ownership attribution and instrument terms
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 28, 2019 Filed Oct 30, 2019 20:04 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,873 | $270.05 | $1,315,953.65 |
DisclosureSEC source: 0001127602-19-031260 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,615 F2 · price: This transaction was executed in multiple trades at prices ranging from $269.64 to $270.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 20:04 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,713 | $269.08 | $1,268,174.04 |
DisclosureSEC source: 0001127602-19-031260 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,488 F1 · price: This transaction was executed in multiple trades at prices ranging from $268.60 to $269.48. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:09 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 12,187 | $0.00 Strike: $307.68 | $0.00 |
DisclosureSEC source: 0001127602-19-009901 · form4.xml · derivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,187 Underlying: Common Stock · 12,187 shares Expires 2029-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 12,187 shares, and is exercisable in three annual installments, with two installments of 4,062 shares each and one installment of 4,063 shares, beginning on 3/1/2020, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:09 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009901 · form4.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,201 F3 · shares: Represents restricted share units. Restrictions lapse as follows: 880 shares each on 3/1/2020 and 3/1/2021, and 881 on 3/1/2022. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:09 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 12,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009901 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,560 F2 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/19. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:09 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 7,812 | $307.68 | $2,403,596.16 |
DisclosureSEC source: 0001127602-19-009901 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,394 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 27, 2018 Filed Dec 28, 2018 21:19 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 2,000 | $256.95 | $513,900.00 |
DisclosureSEC source: 0001127602-18-037494 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,206 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $256.90 to $257.00. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 27, 2018 Filed Dec 28, 2018 21:19 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,000 | $255.03 | $255,030.00 |
DisclosureSEC source: 0001127602-18-037494 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,206 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 400 | $280.35 | $112,140.00 |
DisclosureSEC source: 0001127602-18-034756 · form4.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,206 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. F5 · price: This transaction was executed in multiple trades at prices ranging from $280.29 to $280.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 900 | $279.30 | $251,370.00 |
DisclosureSEC source: 0001127602-18-034756 · form4.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,606 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. F4 · price: This transaction was executed in multiple trades at prices ranging from $278.79 to $279.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 2,500 | $278.22 | $695,550.00 |
DisclosureSEC source: 0001127602-18-034756 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,506 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. F3 · price: This transaction was executed in multiple trades at prices ranging from $277.78 to $278.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 700 | $277.29 | $194,103.00 |
DisclosureSEC source: 0001127602-18-034756 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,006 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $276.73 to $277.71. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 31, 2018 Filed May 7, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,000 | $270.00 | $270,000.00 |
DisclosureSEC source: 0001156039-21-000043 · wf-form4_162041945933437.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,544 F1 · balance_after: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. Due to administrative error, this transaction was not previously reported on a Form 4. As a result, the reporting person's Forms 4 filed since the date of this transaction have overstated the reporting person's ownership by 1,000 shares. Read SEC document |
| October 26, 2018 Filed Oct 30, 2018 20:11 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 500 | $269.10 | $134,550.00 |
DisclosureSEC source: 0001127602-18-031265 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,706 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. F3 · price: This transaction was executed in multiple trades at prices ranging from $269.08 to $269.19. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 26, 2018 Filed Oct 30, 2018 20:11 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 3,000 | $267.34 | $802,020.00 |
DisclosureSEC source: 0001127602-18-031265 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,206 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $267.00 to $267.71. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 27, 2018 Filed Sep 28, 2018 20:11 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,500 | $270.00 | $1,215,000.00 |
DisclosureSEC source: 0001127602-18-028530 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,206 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 20:36 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,936 | $0.00 Strike: $60.15 | $0.00 |
DisclosureSEC source: 0001127602-18-027110 · form4.xml · derivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,936 shares Expires 2019-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 3,870 shares, and is exercisable in four annual installments, with two installments of 967 shares each and two installments of 968 shares each, beginning on December 31, 2012 which is the three-month anniversary of the option grant date. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 20:36 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,000 | $270.00 | $270,000.00 |
DisclosureSEC source: 0001127602-18-027110 · form4.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,706 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 20:36 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,936 | $270.00 | $522,720.00 |
DisclosureSEC source: 0001127602-18-027110 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,706 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2018. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 20:36 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 1,936 | $60.15 | $116,450.40 |
DisclosureSEC source: 0001127602-18-027110 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 20:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 968 | $266.50 | $257,972.00 |
DisclosureSEC source: 0001127602-18-026465 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,706 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 20:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 2,532 | $265.70 | $672,752.40 |
DisclosureSEC source: 0001127602-18-026465 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,674 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $265.44 to $266.37. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:46 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 16,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010102 · form4.xml · nonDerivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,206 F4 · shares: Represents performance based restricted share units. Restrictions lapsed on 3/2/18. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:46 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 8,751 | $233.08 | $2,039,683.08 |
DisclosureSEC source: 0001127602-18-010102 · form4.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,902 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:46 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 14,761 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001127602-18-010102 · form4.xml · derivative · entry 6 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,761 Underlying: Common Stock · 14,761 shares Expires 2028-03-01 F5 · derivative.exercise_date: The option represents a right to purchase a total of 14,761 shares, and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:46 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 4,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010102 · form4.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,653 F3 · shares: Represents restricted share units. Restrictions lapse as follows: 1,436 shares on 3/1/2019, and 1,437 shares each on 3/1/2020 and 3/1/2021. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:46 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 3,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010102 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,343 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,167 shares each on 3/1/2019 and 3/1/2020, and 1,168 on 3/1/2021. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:46 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 1,205 | $232.04 | $279,608.20 |
DisclosureSEC source: 0001127602-18-010102 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,841 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:03 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 1,690 | $179.20 | $302,848.00 |
DisclosureSEC source: 0001127602-17-016603 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,046 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:15 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 1,556 | $166.00 | $258,296.00 |
DisclosureSEC source: 0001127602-17-010574 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,736 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:23 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 634 | $165.97 | $105,224.98 |
DisclosureSEC source: 0001127602-17-010153 · form4.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,292 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:23 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 19,908 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-17-010153 · form4.xml · derivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,908 Underlying: Common Stock · 19,908 shares Expires 2027-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:23 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 4,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010153 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,926 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,622 shares each on 3/1/2018 and 3/1/2019, and 1,623 on 3/1/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:23 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 706 | $166.97 | $117,880.82 |
DisclosureSEC source: 0001127602-17-010153 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,059 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 654 | $144.69 | $94,627.26 |
DisclosureSEC source: 0001127602-16-070124 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,765 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.